Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 60 clinical trials PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
clinical trials PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
We have 60 clinical trials PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
PhD saved successfully
Programming and implementation of a clinical trials visual testing app platform for assessment of advances in tissue engineering
Apply now for 1st October start. Supervisors. Dr Amy L Sheppard . https://research.aston.ac.uk/en/persons/amy-sheppard. Read more
Identifying core instruments for inclusion in the core outcome set for lichen sclerosus trials (CORALS)
University of Nottingham
Centre for Evidence Based Dermatology, Lifespan & Population Health, School of Medicine
Applications are invited for a PhD studentship (three-years full-time) within the Centre of Evidence Based Dermatology at the University of Nottingham. . Read more
Can digital pathology, radiomics and genomics data predict patient outcomes in solid cancers?
Solid tumour trial datasets are increasing in size and complexity. During their treatment journey and trials participation, patients with an advanced solid cancer will have various scans (CT, MRI, PET) repeated at intervals to assess tumour response (using RECIST guidelines). Read more
Overcoming Metabolic Reprogramming by Non-Hodgkin Lymphoma to Improve Adoptive Cellular Immunotherapies
About the project. Changes in metabolism are a hallmark of cancer development and have profound inhibitory effects on the local anti-tumour immune response. Read more
Nanoparticle synthesis and application in magnetic field hyperthermia for cancer therapy
Research Group:
Chemistry and Biosciences
Magnetic field hyperthermia (MFH) is currently undergoing clinical trials for use in humans. The research to date has shown the effectiveness of the approach in cells and animal models and the initial results from human trials are promising. Read more
The use of Drosophila melanogaster to identify novel therapeutic agents for Alzheimer’s disease
Since 2003, our understanding of the causes of Alzheimer’s disease (AD) have improved considerably, however, in that time only one new drug treatment has been approved. Read more
Integrative data analysis: from novel biomarker-drug response associations to predicting effective drug combinations
Research Group:
Translational Tumour Biology
More than 140 children with cancer die in Australia each year due to the occurrence of resistance to traditional chemotherapy. To improve overall survival rates for high-risk paediatric cancer patients, the Children’s Cancer Institute initiated the Zero Childhood Cancer national personalised medicine trial (PRISM). Read more
Connecting All-Island Clinical and Molecular Data for Lymphoid Blood Cancers to Illuminate Immune Dysfunction and Drug Resistance
Research Group:
The Patrick G Johnston Centre for Cancer Research
Part of the multimillion eHealth Hub for Cancer Centre of Excellence led by University of Limerick and Queen’s University Belfast, this PhD studentship contributes to developing open source frameworks to enable federated sharing of all-island clinical and genomics cancer data. Read more
Last chance to apply
MSc By Research: Development and validation of pre-clinical translational assessments for apathy-like behaviour
Apathy is one of the biggest neurological problems of our times. It is a neuropsychiatric symptom associated with many brain disorders and is the most common form of behavioural and psychological anomaly in Alzheimer’s disease, Parkinsonism, dementia, depression and schizophrenia. Read more
Understanding the role of pre-clinical inflammation on contact lens discomfort
The project would aim to characterise patients between symptomatic and asymptomatic contact lens wearers, between patients who can wear contact lenses comfortably and who have dropped contact lens wear due to discomfort. Read more
Studying biological variation in the environmental sensor and novel psoriasis drug target Aryl Hydrocarbon Receptor (AHR): expression, regulation and biomarker potential
Psoriasis is an immune-mediated, chronic inflammatory skin condition due to combination of genetic predisposition, environmental triggers, and dysregulated innate and adaptive immune responses (1). Read more
Deep learning and bioinformatics approaches for personalised medicine
An exciting opportunity to work within a highly multidisciplinary group at the Biomedical AI and Data Science Lab (www.hebasailem.com) at the School of Cancer and Pharmaceutical Sciences to develop new computational pathology approaches to improve cancer patient treatment and diagnosis. Read more
Cancer: Complex 3D modelling of the tumour microenvironment for immunotherapy combination screening
Cancer immunotherapy holds significant promise for the treatment of a range of cancers. Read more
Improving the detection of Developmental Hip Dysplasia in Infants
Description. Developmental Dysplasia of the hip (DDH) is a problem of the hip in babies. Babies can be born with a hip that is completely out of the socket (‘dislocated’), or one that wobbles in and out (‘subluxes’). Read more
Development of a learning health system for orthopaedic surgery using artificial intelligence (AI) and machine learning (ML) techniques
Aims. To develop a learning health system for orthopaedic surgery within the Scottish NHS. Rationale - A learning health system is a system of healthcare that is designed to continuously learn and improve over time by using data and technology to inform clinical practice and research. Read more